Search clinical trials for: NRT

Total 296 results

Merck Sharp & Dohme LLC

Completed

A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)

HIV Infections
ANRS, Emerging Infectious Diseases

Unknown

Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa (THILAO)

HIV Infection

Burkina Faso, Côte D'Ivoire, Mali, Senegal
National Institute on Drug Abuse (NIDA)

Completed

Maintaining Abstinence in Chronic Cigarette Smokers - 1

Tobacco Use Disorder

United States
Pfizer

Completed

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (CATS)

Smoking Cessation

United States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Argentina, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia
Gilead Sciences
Janssen Research & Development, LLC

Completed

Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

HIV Infections | Acquired Immunodeficiency Syndrome

United States, Puerto Rico
Hoffmann-La Roche

Completed

A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

HIV Infections

United Kingdom
The University of Hong Kong

Completed

Motivating Smokers at Outdoor Public Smoking Hotspots to Have Quit Attempt With Nicotine Replacement Therapy Sampling

Smoking Cessation

Hong Kong
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Reducing Tobacco Related Health Disparities

Smoking | Smoking Cessation

United States
Pfizer
GlaxoSmithKline

Completed

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders (EAGLES)

Smoking Cessation

United States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia, Argentina
University of California, Los Angeles
Philip Morris USA, Inc.

Completed

Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking

Cigarette Smoking Behavior

United States
Gilead Sciences

Completed

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

HIV Infections | Acquired Immunodeficiency Syndrome

Puerto Rico, United States, United Kingdom, Canada, Germany, Austria, Australia, Dominican Republic, Mexico
Oslo University Hospital

Completed

Transdermal Nicotine Replacement in Smokers With Acute Aneurysmal Subarachnoid Hemorrhage (NRT-SAH)

Aneurysmal Subarachnoid Hemorrhage

Norway
Yale University
Bristol-Myers Squibb; Merck Sharp & Dohme LLC

Completed

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

HIV Infections | Human Immunodeficiency Virus | AIDS | Acquired Immune Deficiency Syndrome

United States
Kirby Institute

Completed

MARCH Vascular Endothelium Substudy (MARCH VE)

Cardiovascular Disease

Argentina, Australia, Germany, Thailand
Duke University
National Institute on Drug Abuse (NIDA); Philip Morris USA, Inc.

Completed

Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers (ConNic5)

Nicotine Dependence

United States
Creighton University

Terminated

e-Cigarettes Versus NRT Gum for Smoking Cessation

Smoking Cessation | Nicotine Addiction

United States
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials Network

Unknown

The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers (CANQUIT)

Smoking Cessation | HIV

Canada
Gilead Sciences

Completed

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

HIV-1 Infection

United States, Spain, United Kingdom, Canada, Puerto Rico, France, Belgium, Italy, Germany, Austria
University of Wisconsin, Madison

Completed

Relationship Between HIV-1 Subtype and ARV Response (RELATES)

HIV Infections

Uganda
Nantes University Hospital

Withdrawn

Dolutegravir + Rilpivirine Switch Study (DORISS) (DORISS)

HIV Infection | HAART-treated | Virologically Controlled

France
University of Minnesota
National Cancer Institute (NCI)

Completed

Offering Proactive Tobacco Treatment

Tobacco Use Cessation

United States
Massachusetts General Hospital

Terminated

Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia

Schizophrenia | Nicotine Dependence

United States
University of Minnesota
Merck Sharp & Dohme LLC

Withdrawn

Raltegravir Activity In Lymphoid Tissues

HIV Infections | HIV Infection

United States
Fundacion SEIMC-GESIDA
Bristol-Myers Squibb

Completed

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy (SALT)

HIV Infection

Spain
University of California, Los Angeles
Philip Morris USA

Completed

Youth Smoking Cessation: Therapy +/- "The Patch"

Smoking

United States
National Center for Global Health and Medicine,...
Ministry of Health, Labour and Welfare, Japan

Completed

Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir (SPARE)

HIV Infections

Japan
Augusta University
National Cancer Institute (NCI)

Completed

The Impact of a Tobacco Control Intervention in African-American Families

Tobacco Cessation | Tobacco Prevention | Environmental Tobacco Smoke Exposure

United States
University of Connecticut

Completed

Impact of Smoking Cessation and γ-Tocopherol to Restore Vascular Endothelial Function

Endothelial Dysfunction

United States
Oregon Center for Applied Science, Inc.

Completed

Pharmacological Aids for Interactive Smoking Cessation (NRT_2)

Smoking Cessation
University of South Florida
Merck Sharp & Dohme LLC; St. Joseph's Hospital, Florida

Completed

A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen

Virus Diseases | HIV

United States
University of Nottingham

Completed

Experiences of Pregnant Women Who Use NRT in Pregnancy as Part of a Quit Attempt

Pregnancy | Nicotine Replacement Therapy | Qualitative

United Kingdom
Southern Illinois University Carbondale
National Institute on Drug Abuse (NIDA)

Completed

Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers

Nicotine Dependence

United States
GlaxoSmithKline

Completed

A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine Lozenges

Healthy Volunteer Smokers
University of British Columbia
Boehringer Ingelheim; Abbott; CIHR Canadian HIV Trials Network

Completed

NRTI-Sparing Pilot Study

HIV | Mitochondrial Toxicity

Canada
Boehringer Ingelheim

Completed

Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients

HIV Infections
Yale University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Treating Low-Income Smokers in the Hospital Emergency Department

Smoking | Smoking Cessation | Tobacco Use Disorder | Tobacco Use Cessation

United States
Duke University
National Cancer Institute (NCI)

Terminated

Testing Pharmacological Therapies for Pregnant Smokers

Smoking | Pregnancy

United States
Boehringer Ingelheim

Completed

Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens

HIV Infections
Boehringer Ingelheim

Terminated

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

HIV Infections

United States, Argentina, Brazil, Canada, Germany, Italy, Spain
Tibotec Pharmaceuticals, Ireland

Completed

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

Human Immunodeficiency Virus Type 1

United States, France, United Kingdom, China, Germany, South Africa, Russian Federation, Argentina, Brazil, Puerto Rico, Austria, Thailand, Mexico, Uganda
Mayo Clinic

Completed

Highdose Nicotine Patch Therapy for Smokeless Tobacco Use

Smokeless Tobacco Use

United States
University of British Columbia
St. Paul's Hospital, Canada; Providence Health & Services

Completed

Nicotine Replacement Provided at a Tertiary Care Hospital (N-PATCH)

Smoking Cessation

Canada
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

HIV Infections

United States
Janssen R&D Ireland

Completed

TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients

HIV Infections | Acquired Immunodeficiency Syndrome

United States, France, Argentina, South Africa, Thailand
GlaxoSmithKline

Completed

Provoked Craving Relief Study by NRT (NRT)

Smoking Cessation

United States
French National Agency for Research on AIDS and...
Tibotec Pharmaceutical Limited

Completed

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

HIV Infections

France
University of Messina

Completed

Inofolic NRT and the Metabolic Syndrome

Metabolic Syndrome | Postmenopausal Disorder

Italy
Janssen-Cilag S.p.A.

Completed

A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients (MONARCH)

Human Immunodeficiency Virus 1
Tibotec Pharmaceuticals, Ireland

Completed

A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study

Human Immunodeficiency Virus Type 1
GlaxoSmithKline

Completed

Oral Tolerability Of Two Nicotine Dosage Forms

Healthy Volunteer Smokers

Search clinical trials for: NRT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations